Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Korea-U.S. Free Trade Talks Extended; Korean Media Speculates Pharma Revisions

This article was originally published in PharmAsia News

Executive Summary

SEOUL - Negotiators from South Korea and the U.S. are extending the second round of talks, aimed at revising a bilateral free trade agreement pact agreed upon three years ago, until Dec. 2 in the U.S. The deadline extension has triggered speculation in Seoul that the Korean negotiators might call for a revision of the FTA's pharma section in return for a compromise on the thorniest issue surrounding U.S. car exports to Korea
Advertisement

Related Content

Delay In Approval Of U.S.-Korea Free Trade Agreement Could Give EU Companies Advantage Over U.S. Counterparts
Delay In Approval Of U.S.-Korea Free Trade Agreement Could Give EU Companies Advantage Over U.S. Counterparts
Korea-EU Free Trade Agreement Creates Another Threat To Local Korean Pharmas; Good For MNCs
Advertisement
UsernamePublicRestriction

Register

SC073852

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel